Vasoactive Intestinal Peptide (VIP) is a 28–amino acid neuropeptide extensively studied for its regulatory role in neuroimmune communication, smooth muscle signaling, and cellular homeostasis. VIP is naturally expressed in the central and peripheral nervous systems and is involved in coordinating immune balance, circadian signaling, and epithelial function.
In research settings, VIP is commonly explored for its role in immune modulation, anti-inflammatory signaling, neuroprotection, and vascular regulation. Suggested areas of investigation include cytokine balance, gut–brain axis communication, pulmonary and gastrointestinal signaling, and cellular stress response pathways. VIP has also been studied in models related to mitochondrial support, metabolic regulation, and tissue resilience under inflammatory conditions.
Its broad receptor distribution (VPAC1 and VPAC2) makes VIP particularly valuable for systems-level research examining coordinated signaling between immune cells, neurons, and epithelial tissues.
Vasoactive Intestinal Peptide (VIP) is a multifunctional neuropeptide belonging to the secretin/glucagon peptide family. Since its discovery, VIP has been recognized as a key signaling molecule linking the nervous, immune, and endocrine systems. It exerts its biological effects primarily through VPAC1 and VPAC2 receptors, which are widely expressed across immune cells, epithelial tissues, smooth muscle, and neural structures.
One of the most extensively studied properties of VIP is its ability to regulate inflammatory signaling. In multiple experimental models, VIP suppresses the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-12 while promoting anti-inflammatory mediators like IL-10. This dual regulatory role makes VIP an important research peptide for investigating immune tolerance, chronic inflammation, and autoimmune signaling mechanisms.
VIP also plays a significant role in gastrointestinal research. It influences intestinal motility, epithelial secretion, and mucosal barrier integrity. Studies have shown that VIP contributes to maintaining gut homeostasis by modulating immune cell activity within the intestinal environment and supporting epithelial cell survival. These properties have positioned VIP as a subject of interest in research related to inflammatory bowel conditions and gut–immune interactions.
In the respiratory system, VIP has been studied for its effects on smooth muscle relaxation and inflammatory control. Experimental data suggest VIP can reduce airway inflammation, inhibit immune cell infiltration, and support epithelial repair, making it relevant in pulmonary and airway inflammation research models.
Neurological research highlights VIP’s neuroprotective and neuromodulatory roles. VIP influences neuronal survival, synaptic plasticity, and circadian rhythm regulation through its action in the hypothalamus and cortex. It has also been studied in models of neuroinflammation and neurodegeneration, where it appears to reduce microglial activation and oxidative stress.
At the cellular level, VIP has been shown to support mitochondrial function, reduce oxidative damage, and regulate apoptosis-related pathways. These effects extend its relevance into metabolic research, aging-related cellular studies, and investigations focused on cellular stress resilience.
Collectively, VIP is valued in research for its broad signaling capabilities and its role as a central coordinator of immune, neural, and epithelial communication.
Research & References:
Research on Vasoactive Intestinal Peptide has consistently demonstrated its central role in maintaining immune and tissue equilibrium. Early investigations identified VIP as a potent vasodilator and smooth muscle relaxant, but subsequent studies revealed far broader biological significance, particularly in immune regulation and neuroimmune signaling.
In immune research, VIP is widely recognized for shifting immune responses away from pro-inflammatory Th1 and Th17 pathways toward anti-inflammatory and regulatory phenotypes. Experimental models show VIP reduces macrophage activation, inhibits dendritic cell maturation, and promotes regulatory T-cell activity. These effects are mediated through cyclic AMP (cAMP) signaling and downstream transcriptional regulation, including inhibition of NF-κB and MAPK pathways.
Gastrointestinal studies emphasize VIP’s role in preserving epithelial integrity and regulating gut motility and secretion. Animal models demonstrate that disruption of VIP signaling leads to increased intestinal inflammation and epithelial damage, while restoration of VIP activity supports mucosal healing and immune balance within the gut.
Pulmonary research highlights VIP’s protective effects in airway inflammation models. Studies show reduced cytokine release, decreased immune cell infiltration, and improved epithelial resilience in the presence of VIP signaling. These findings support ongoing interest in VIP within respiratory and inflammatory lung research.
Neuroscience research has identified VIP as a critical modulator of circadian rhythm regulation and neuronal survival. VIP-expressing neurons in the suprachiasmatic nucleus coordinate circadian signaling, while broader neuroprotective effects have been observed in models of oxidative stress and neuroinflammation.
Overall, existing research positions VIP as a foundational peptide for studying integrated signaling between the nervous system, immune system, and epithelial tissues. Its pleiotropic actions and well-characterized receptor pathways make it a powerful tool for advanced experimental research into inflammation, neuroprotection, and systemic cellular communication.
Selected Research References:
